Immunic Newsroom

B.Riley Financial Maintains Immunic(IMUX.US) With Buy Rating, Maintains Target Price $6

Futu NewsNov 26 14:32

Immunic's Promising Pipeline Progress and Stable Financials Justify Buy Rating

TipRanksNov 26 14:08

Immunic Price Target Announced at $10.00/Share by HC Wainwright & Co.

Dow JonesNov 25 21:35

Immunic Analyst Ratings

BenzingaNov 25 21:25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Adaptimmune Therapeutics (ADAP), Fulcrum Therapeutics (FULC) and Immunic (IMUX)

TipRanksNov 19 15:26

Optimistic Buy Rating for Immunic Driven by Promising Trials and Market Opportunities for VidoCa

TipRanksNov 11 14:31

Immunic Analyst Ratings

BenzingaNov 7 21:35

EF Hutton Maintains Buy on Immunic, Maintains $17 Price Target

BenzingaNov 7 21:35

Immunic Analyst Ratings

BenzingaOct 22 19:49

EF Hutton Maintains Buy on Immunic, Maintains $17 Price Target

BenzingaOct 22 19:48

Immunic Stock's Popularity Rises With Consistent Buy Ratings From Analysts

TipRanksOct 21 19:27

Brookline Capital Maintains Immunic(IMUX.US) With Buy Rating, Raises Target Price to $13

Futu NewsOct 17 19:37

Analysts Are Bullish on Top Healthcare Stocks: Bluebird Bio (BLUE), Immunic (IMUX)

TipRanksSep 25 17:07

B.Riley Financial Maintains Immunic(IMUX.US) With Buy Rating, Maintains Target Price $6

Futu NewsSep 24 10:31

B.Riley Financial Maintains Immunic(IMUX.US) With Buy Rating, Maintains Target Price $6

Futu NewsSep 17 13:32

Buy Rating Affirmed for Immunic, Inc. on Promising MS Drug Developments and Favorable Market Position

TipRanksSep 17 13:18

Immunic Initiated at Buy by EF Hutton

Dow JonesSep 16 20:36

Immunic Analyst Ratings

BenzingaSep 16 20:27

EF Hutton Initiates Coverage On Immunic With Buy Rating, Announces Price Target of $17

BenzingaSep 16 20:26

Leerink Partners Initiates Immunic(IMUX.US) With Buy Rating, Announces Target Price $5

Futu NewsSep 9 18:33